NVGN Share Price

Open 1.68 Change Price %
High 1.90 1 Day 0.02 1.18
Low 1.67 1 Week -0.02 -1.15
Close 1.72 1 Month 0.08 4.88
Volume 47240 1 Year -0.19 -9.95
52 Week High 2.85
52 Week Low 1.39
NVGN Important Levels
Resistance 2 1.93
Resistance 1 1.85
Pivot 1.76
Support 1 1.59
Support 2 1.51
NASDAQ USA Most Active Stocks
DRYS 2.24 -4.68%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
ASTI 0.00 0.00%
More..
NASDAQ USA Top Gainers Stocks
MYRX 0.10 100.00%
LOCM 0.09 50.00%
CEMP 4.05 28.57%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SKBI 0.10 25.00%
IPCI 2.55 18.60%
QKLS 0.15 15.38%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
GMETP 0.70 -59.54%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
EDMC 0.01 -50.00%
QTWW 0.08 -50.00%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

Novogen Limited (NASDAQ: NVGN)

NVGN Technical Analysis 2
As on 24th Feb 2017 NVGN Share Price closed @ 1.72 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.89 & Strong Buy for SHORT-TERM with Stoploss of 1.61 we also expect STOCK to react on Following IMPORTANT LEVELS.
NVGN Target for February
1st Target up-side 1.77
2nd Target up-side 1.92
3rd Target up-side 2.07
1st Target down-side 1.35
2nd Target down-side 1.2
3rd Target down-side 1.05
NVGN Other Details
Segment EQ
Market Capital 82721968.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.novogen.com
NVGN Address
NVGN
16 - 20 Edgeworth David Avenue
Level 1
Hornsby, NSW 2077
Australia
Phone: 61 2 9476 0344
Fax: 61 2 9476 0388
NVGN Latest News
What We're Trading: Stericycle Inc (SRCL) Technical Backdrop Turns Bullish   Schaeffers Research (blog)   - 18th Jan 17
Must Watch Stocks for October 31, 2016   Benzinga   - 31st Oct 16
Novogen Limited: Edison Investment Research Report maintains valuation as ...   The Wall Street Transcript   - 10th May 16
Analyst Downgrades: Gilead Sciences, Inc., Skyworks Solutions Inc, and ...   Schaeffers Research (blog)   - 29th Apr 16
6 ASX BioTechs Trading on the NASDAQ   TheBull.com.au   - 03rd Apr 16
Biotech Stocks Today: MannKind Corporation (MNKD), Celgene Corporation (CELG ...   CNA Finance (press release)   - 16th Jul 15
Novogen (NVGN) Stock | Why We're Seeing The Declines Today   CNA Finance (press release)   - 21st Apr 15
Lufkin Industries, Inc. (LUFK), Bank of America Corp (BAC), Palmeto Bancshares ...   Insider Monkey (blog)   - 08th Apr 13
Novogen Ltd. ADR NVGN (US: Nasdaq)   Wall Street Journal   - 13th Feb 11
Prana Biotechnology Ltd. ADR PRAN (US: Nasdaq)   Wall Street Journal   - 11th Feb 11
Interactive Technical Analysis Chart Novogen Limited ( NVGN NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Novogen Limited
NVGN Business Profile
Novogen Limited is engaged in pharmaceutical research and development, and marketing of consumer healthcare products. The Company has three segments: Drug Development, Oncology Drug Program, Consumer Business and Wound Healing. Drug Development includes the discovery of new compounds and the early stage screening for bioactivity of such compounds through both in vivo and in vitro testing. Oncology Drug Program involves the development of selected oncology drug candidates, which have indicated bioactivity against cancer cells through clinical trial programs to assess safety and efficacy. Wound Healing is a separate technology based on Beta-1 Glucan to aid in the management of wounds. The Company�s clinical development program run through Novogen�s subsidiaries Marshall Edwards, Inc. (MEI) and Glycotex, Inc. (Glycotex). In October 2013, Novogen Limited acquired a drug technology.